Literature DB >> 24473237

A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening.

Christophe J Queval1, Ok-Ryul Song, Vincent Delorme, Raffaella Iantomasi, Romain Veyron-Churlet, Nathalie Deboosère, Valérie Landry, Alain Baulard, Priscille Brodin.   

Abstract

Despite the availability of therapy and vaccine, tuberculosis (TB) remains one of the most deadly and widespread bacterial infections in the world. Since several decades, the sudden burst of multi- and extensively-drug resistant strains is a serious threat for the control of tuberculosis. Therefore, it is essential to identify new targets and pathways critical for the causative agent of the tuberculosis, Mycobacterium tuberculosis (Mtb) and to search for novel chemicals that could become TB drugs. One approach is to set up methods suitable for the genetic and chemical screens of large scale libraries enabling the search of a needle in a haystack. To this end, we developed a phenotypic assay relying on the detection of fluorescently labeled Mtb within fluorescently labeled host cells using automated confocal microscopy. This in vitro assay allows an image based quantification of the colonization process of Mtb into the host and was optimized for the 384-well microplate format, which is proper for screens of siRNA-, chemical compound- or Mtb mutant-libraries. The images are then processed for multiparametric analysis, which provides read out inferring on the pathogenesis of Mtb within host cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24473237      PMCID: PMC4089478          DOI: 10.3791/51114

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Authors:  Neel R Gandhi; Paul Nunn; Keertan Dheda; H Simon Schaaf; Matteo Zignol; Dick van Soolingen; Paul Jensen; Jaime Bayona
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

3.  Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure.

Authors:  Jean-Philippe Carralot; Tae-Kyu Kim; Boris Lenseigne; Annette S Boese; Peter Sommer; Auguste Genovesio; Priscille Brodin
Journal:  J Biomol Screen       Date:  2009-02-04

Review 4.  Statistical methods for analysis of high-throughput RNA interference screens.

Authors:  Amanda Birmingham; Laura M Selfors; Thorsten Forster; David Wrobel; Caleb J Kennedy; Emma Shanks; Javier Santoyo-Lopez; Dara J Dunican; Aideen Long; Dermot Kelleher; Queta Smith; Roderick L Beijersbergen; Peter Ghazal; Caroline E Shamu
Journal:  Nat Methods       Date:  2009-08       Impact factor: 28.547

5.  Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis.

Authors:  K A McDonough; Y Kress
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling.

Authors:  Priscille Brodin; Yannick Poquet; Florence Levillain; Isabelle Peguillet; Gerald Larrouy-Maumus; Martine Gilleron; Fanny Ewann; Thierry Christophe; Denis Fenistein; Jichan Jang; Mi-Seon Jang; Sei-Jin Park; Jean Rauzier; Jean-Philippe Carralot; Rachel Shrimpton; Auguste Genovesio; Jesus A Gonzalo-Asensio; Germain Puzo; Carlos Martin; Roland Brosch; Graham R Stewart; Brigitte Gicquel; Olivier Neyrolles
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

7.  Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells.

Authors:  Hye-Mi Lee; Jae-Min Yuk; Dong-Min Shin; Eun-Kyeong Jo
Journal:  J Clin Immunol       Date:  2009-07-25       Impact factor: 8.317

8.  Mycobacterium tuberculosis invades and replicates within type II alveolar cells.

Authors:  L E Bermudez; J Goodman
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation.

Authors:  K M Dobos; E A Spotts; F D Quinn; C H King
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 10.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

View more
  14 in total

1.  System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis.

Authors:  Xingji Zheng; Yossef Av-Gay
Journal:  J Vis Exp       Date:  2017-04-05       Impact factor: 1.355

2.  ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton.

Authors:  Ok-Ryul Song; Christophe J Queval; Raffaella Iantomasi; Vincent Delorme; Sabrina Marion; Romain Veyron-Churlet; Elisabeth Werkmeister; Michka Popoff; Isabelle Ricard; Samuel Jouny; Nathalie Deboosere; Frank Lafont; Alain Baulard; Edouard Yeramian; Laurent Marsollier; Eik Hoffmann; Priscille Brodin
Journal:  EMBO Rep       Date:  2017-11-15       Impact factor: 8.807

3.  A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.

Authors:  Kaitlyn Schaaf; Virginia Hayley; Alexander Speer; Frank Wolschendorf; Michael Niederweis; Olaf Kutsch; Jim Sun
Journal:  Assay Drug Dev Technol       Date:  2016-06-21       Impact factor: 1.738

4.  A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis.

Authors:  Kaitlyn Schaaf; Samuel R Smith; Virginia Hayley; Olaf Kutsch; Jim Sun
Journal:  J Vis Exp       Date:  2017-03-24       Impact factor: 1.355

5.  Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.

Authors:  Flavia Sorrentino; Ruben Gonzalez del Rio; Xingji Zheng; Jesus Presa Matilla; Pedro Torres Gomez; Maria Martinez Hoyos; Maria Esther Perez Herran; Alfonso Mendoza Losana; Yossef Av-Gay
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

Review 6.  Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Authors:  Lloyd Tanner; Paolo Denti; Lubbe Wiesner; Digby F Warner
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

Review 7.  Fluorescent Mycobacterium tuberculosis reporters: illuminating host-pathogen interactions.

Authors:  Nathan J MacGilvary; Shumin Tan
Journal:  Pathog Dis       Date:  2018-04-01       Impact factor: 3.166

8.  Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles.

Authors:  Joana Costa-Gouveia; Elisabetta Pancani; Samuel Jouny; Arnaud Machelart; Vincent Delorme; Giuseppina Salzano; Raffaella Iantomasi; Catherine Piveteau; Christophe J Queval; Ok-Ryul Song; Marion Flipo; Benoit Deprez; Jean-Paul Saint-André; José Hureaux; Laleh Majlessi; Nicolas Willand; Alain Baulard; Priscille Brodin; Ruxandra Gref
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

9.  A high-throughput screening assay based on automated microscopy for monitoring antibiotic susceptibility of Mycobacterium tuberculosis phenotypes.

Authors:  Sadaf Kalsum; Blanka Andersson; Jyotirmoy Das; Thomas Schön; Maria Lerm
Journal:  BMC Microbiol       Date:  2021-06-05       Impact factor: 3.605

10.  STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection.

Authors:  Christophe J Queval; Ok-Ryul Song; Nathalie Deboosère; Vincent Delorme; Anne-Sophie Debrie; Raffaella Iantomasi; Romain Veyron-Churlet; Samuel Jouny; Keely Redhage; Gaspard Deloison; Alain Baulard; Mathias Chamaillard; Camille Locht; Priscille Brodin
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.